We are a biotechnology company. We specialize in scientific research in the field of human nutrition, dietary supplementation and dermocosmetics. We are developing especially those areas of science that contribute to an effective and safe reduction of overweight, change of nutritional profiles and inhibition of changes and aging of skin cells.
The leading brand among our supplements is NOVOSLIM, a modern preparation supporting the slimming process, while for those who value a healthy lifestyle, we offer INULINA - a natural prebiotic in the purest form, made from chicory root.
We invite you to familiarize yourself with our offer on our website.
10.86.Z - Manufacture of homogenised food preparations and dietetic food
47.91.Z - Retail sale via mail order houses or via Internet
71.20.A - Food quality testing and analysis
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 260,2 | 23,1 | 8,7 | -62,3 |
EBITDA | 273,1 | 38,1 | 15,2 | -60,2 |
Short time liabilities | 50 | 71,2 | 117,8 | 65,4 |
Equity capital | 376,4 | 396,8 | 403,8 | 1,8 |
Operating profit (EBIT) | 264,8 | 29,3 | 11,2 | -61,9 |
Assets | 451 | 480,6 | 523,9 | 9 |
Net profit (loss) | 235,8 | 20,1 | 7 | -64,9 |
Cash | 305,4 | 305,1 | 353,2 | 15,8 |
Liabilities and provisions for liabilities | 74,6 | 83,9 | 120,1 | 43,3 |
Net income from sale | 805,9 | 249,6 | 200,4 | -19,7 |
Working assets | 451 | 480,6 | 523,9 | 9 |
Depreciation | 8,3 | 8,8 | 4 | -54,5 |
% | % | % | p.p. | |
Profitability of capital | 62,6 | 5,1 | 1,7 | -3,4 |
Equity capital to total assets | 83,5 | 82,6 | 77,1 | -5,5 |
Gross profit margin | 32,3 | 9,2 | 4,3 | -4,9 |
EBITDA Margin | 33,9 | 15,3 | 7,6 | -7,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 23 | 104 | 215 | 111 |
Current financial liquidity indicator | 9.017197608947754 | 6.749359130859375 | 4.449010372161865 | -2,3 |
Net dept to EBITDA | -1.0284041166305542 | -7.668229579925537 | -23.112329483032227 | -15,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane